Although several studies have reported the association of CASP9 Ex5 +32G>A polymorphism with cancer susceptibility, the results of present study however, failed to reveal significant association of this polymorphism with the development and progression CML. This evidence concerns the gene CASP9 and chronic myelogenous leukemia, BCR-ABL1 positive.